Combining zwitterionic chemistry with nanomaterials, a novel coating may advance biosensor technology for accurate drug monitoring in the body's toughest conditions.

Staphylococcus aureus infections remain a formidable health threat, responsible for the most infection-related deaths worldwide and a mortality rate of up to 30%, despite contemporary infection ...

A triple dose of Novo Nordisk's GLP-1 agonist Wegovy has shown improved activity on weight loss in an obesity trial, as the drugmaker tries to fend off a marketplace challenge from Eli Lilly. A 7.2mg ...

UK medtech firm Closed Loop Medicine has launched its first product in the US, a digital tool for personalising the dose of GLP-1 agonist-based weight loss therapies. The WeDosify software promises to ...

The global intracameral antibiotics market is poised for significant expansion, with projections indicating growth from USD 57.6 million in 2025 to approximately USD 89.5 million by 2035. This ...